266 related articles for article (PubMed ID: 28374979)
1. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
Parente JM; Pereira CA; Oliveira-Paula GH; Tanus-Santos JE; Tostes RC; Castro MM
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
Blascke de Mello MM; Parente JM; Schulz R; Castro MM
Vascul Pharmacol; 2019 May; 116():36-44. PubMed ID: 30339939
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension.
Belo VA; Parente JM; Tanus-Santos JE; Castro MM
Biochem Pharmacol; 2016 Oct; 118():50-58. PubMed ID: 27531060
[TBL] [Abstract][Full Text] [Related]
4. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats.
Castro MM; Cena J; Cho WJ; Walsh MP; Schulz R
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):662-8. PubMed ID: 22199370
[TBL] [Abstract][Full Text] [Related]
6. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
[TBL] [Abstract][Full Text] [Related]
7. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
Pereira SC; Parente JM; Belo VA; Mendes AS; Gonzaga NA; do Vale GT; Ceron CS; Tanus-Santos JE; Tirapelli CR; Castro MM
Atherosclerosis; 2018 Mar; 270():146-153. PubMed ID: 29425960
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
[TBL] [Abstract][Full Text] [Related]
9. Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats.
Callera GE; Yeh E; Tostes RC; Caperuto LC; Carvalho CR; Bendhack LM
Br J Pharmacol; 2004 Apr; 141(7):1151-8. PubMed ID: 15006902
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
Castro MM; Rizzi E; Ceron CS; Guimaraes DA; Rodrigues GJ; Bendhack LM; Gerlach RF; Tanus-Santos JE
Nitric Oxide; 2012 Mar; 26(3):162-8. PubMed ID: 22327038
[TBL] [Abstract][Full Text] [Related]
11. Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension.
de Oliveira Neves VG; Blascke de Mello MM; Rodrigues D; Pernomian L; de Oliveira IS; Parente JM; Arantes EC; Tostes RC; Castro MM
Vascul Pharmacol; 2023 Oct; 152():107211. PubMed ID: 37607602
[TBL] [Abstract][Full Text] [Related]
12. The Labdane Ent-3-Acetoxy-Labda-8(17), 13-Dien-15-Oic Decreases Blood Pressure In Hypertensive Rats.
Simplicio JA; Simão MR; Ambrosio SR; Tirapelli CR
Arq Bras Cardiol; 2016 Jun; 106(6):481-90. PubMed ID: 27096521
[TBL] [Abstract][Full Text] [Related]
13. Morphological and functional alterations of mesenteric small resistance arteries in early renal hypertension in rats.
Deng LY; Schiffrin EL
Am J Physiol; 1991 Oct; 261(4 Pt 2):H1171-7. PubMed ID: 1928399
[TBL] [Abstract][Full Text] [Related]
14. Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium.
Molin JC; Sguilla FS; Bendhack LM
Eur J Pharmacol; 2005 Oct; 522(1-3):94-9. PubMed ID: 16188252
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension.
Belo VA; Guimarães DA; Castro MM
J Vasc Res; 2015; 52(4):221-31. PubMed ID: 26731549
[TBL] [Abstract][Full Text] [Related]
16. Impaired relaxation to acetylcholine in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors.
Callera GE; Varanda WA; Bendhack LM
Gen Pharmacol; 2000 Jun; 34(6):379-89. PubMed ID: 11483287
[TBL] [Abstract][Full Text] [Related]
17. Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease.
Quek KJ; Boyd R; Ameer OZ; Zangerl B; Butlin M; Murphy TV; Avolio AP; Phillips JK
Vascul Pharmacol; 2016 Jun; 81():42-52. PubMed ID: 26771067
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
Guimarães DA; Rizzi E; Ceron CS; Martins-Oliveira A; Gerlach RF; Shiva S; Tanus-Santos JE
Redox Biol; 2015 Dec; 6():386-395. PubMed ID: 26343345
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha.
Besnard S; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Tedgui A; Henrion D
Circ Res; 2002 Apr; 90(7):820-5. PubMed ID: 11964376
[TBL] [Abstract][Full Text] [Related]
20. Caveolae dysfunction contributes to impaired relaxation induced by nitric oxide donor in aorta from renal hypertensive rats.
Rodrigues GJ; Restini CB; Lunardi CN; Moreira JE; Lima RG; da Silva RS; Bendhack LM
J Pharmacol Exp Ther; 2007 Dec; 323(3):831-7. PubMed ID: 17785608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
